Breast Cancer Diagnosis & Treatment Advances (100-word summary)
Pathologists play a crucial role in modern breast cancer care, integrating increasingly complex data - including tumor biomarkers and molecular classifications - to predict treatment response. Advances like mass sequencing and liquid biopsies allow for detailed genetic analysis with minimal tissue, identifying therapeutic targets even in advanced stages.AI is also being explored for objective biomarker quantification. With roughly 37,000 new cases annually in Spain, early screening (from age 45) and personalized therapies, guided by predictive biomarkers (like PD-L1 & BRCA mutations), are vital for improved outcomes and reduced toxicity.